This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using Glaucoma Medications. The Findings May Identify Patients at Greater Risk of Intolerance and Support More Personalized Treatment and Counselling.
Recruiting now NCT07739784
Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · for 18 and older · All sexes
What this study is about
The goal of this observational study is to learn whether personality traits are related to eye side effects from glaucoma medications in adults who currently use or previously used these medications. The main questions this study aims to answer are: Are certain personality traits associated with the occurrence or severity of eye side effects from glaucoma medications? Do personality traits differ between people who experience these side effects and those who do not? Participants will complete a questionnaire that measures five personality traits: openness, conscientiousness, extraversion, agreeableness, and neuroticism. They will also provide basic demographic information. The researchers will review participants' medical records to collect information about their glaucoma medications and any related eye side effects, including the type and frequency of side effects and whether treatment was changed because of them. Participation involves one session lasting approximately 30 minutes. Questionnaires may be completed securely online or in person at the clinic. The study will include approximately 352 adults. No treatment will be assigned or changed as part of this study.
Who can join (things the study team will check)
✅ You may be able to join if…
- Age 18 years or older.
- Diagnosis of glaucoma.
- Current or previous treatment with one or more glaucoma medications.
- Able to provide informed consent.
- Able to complete the study questionnaires in English or French.
🚫 You may not be able to join if…
- Uncontrolled anxiety or depression that was present before glaucoma medication treatment began.
- Unable to provide informed consent.
- Unable to complete the study questionnaires in English or French.
Where this trial is running
- McGill University Health Center, Montreal, Quebec, Canada
Who to contact
Ana Hernandez, MD · 15149341934 · ana.ramirezhernandez@mail.mcgill.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07739784.
Verify everything on the official ClinicalTrials.gov record. Page updated August 2026.